June 10, 2026 Sexual Wellness & Sex Tech Brief: 7 Stories to Watch
A weekly digest covering regulatory updates, industry developments, safety alerts, market research, and Canadian local news across the sexual wellness and sex tech sectors. Compiled by the Dr.Chen Wellness Editorial Team.
This issue spans five corners of the sector at once: a fresh U.S. safety recall of an adulterated enhancement supplement, two Canadian stories tied to federal funding and Pride-season community research, a new long-range market forecast, a product launch from the retail-novelty side of the business, an update on the North American B2B trade calendar, and a security study that puts AI companion apps under the privacy microscope. Read together, they trace the same throughline that has defined 2026 so far — consumer trust is being shaped less by marketing and more by what regulators flag, what data shows, and how safely a product handles the body and the information that surrounds it. Below, each story is broken into the facts, the context, and what it may mean for Canadian readers, retailers, and the wider industry.
1. FDA Posts Nationwide Recall of "WAP Sensual Enhancement" Capsules Over Hidden Drug Ingredients [SAFETY — US]
Fact: On May 11, 2026 (FDA publish date May 18), Los Angeles-based seller Best Supplements Best Prices issued a voluntary nationwide recall of all lots of WAP Sensual Enhancement capsules after FDA laboratory analysis found the product contained undeclared sildenafil, tadalafil, and flibanserin. The supplement had been sold across the United States via eBay.
Background: Sildenafil and tadalafil are prescription erectile-dysfunction drugs, while flibanserin is a prescription treatment for low sexual desire in women. None were disclosed on the label, and all three can interact dangerously with other medications.
Significance: The FDA warns these hidden ingredients can interact with nitrates — common in prescriptions for diabetes, high blood pressure, high cholesterol, and heart disease — and drop blood pressure to dangerous levels; flibanserin adds risks of fainting when combined with alcohol. This can reasonably be viewed as a reminder that "all-natural" enhancement products sold through open marketplaces remain a recurring adulteration risk that Canadian shoppers buying cross-border should treat with caution.
2. Ottawa Commits $5.4 Million to National Sexual and Reproductive Health Organizations [OFFICIAL — CANADA]
Fact: In March 2026, the Honourable Marjorie Michel, Minister of Health, announced more than $5.4 million through the federal Sexual and Reproductive Health (SRH) Fund to support five national organizations working to reduce barriers to services such as abortion, fertility treatment, endometriosis care, and menopause support. A further investment of nearly $600,000 was directed to inclusive, culturally sensitive SRH services for underserved communities.
Background: The SRH Fund, administered by Health Canada, targets populations that face the steepest access gaps, including 2SLGBTQI+, Indigenous, and racialized people, women, and youth.
Significance: Sustained federal funding signals that sexual and reproductive health remains a policy priority in Canada even amid broader fiscal pressures. This may suggest continued institutional support for the education and clinical infrastructure that surrounds the consumer wellness market, and underscores that access — not just product availability — is treated as a public-health concern at the national level.
3. Canadian Community Research Centre Advances 2SLGBTQIA+ Sexual Health Survey for 2026 Findings [RESEARCH — CANADA]
Fact: The Community-Based Research Centre (CBRC), a Canadian non-profit, is preparing to share findings from its national "Our Bodies, Our Health" survey, which gathered responses on 2SLGBTQIA+ sexual and reproductive health priorities at Pride events and community spaces across the country, with results expected to be reported back to communities in 2026.
Background: The survey, developed with the University of Victoria and CBRC's Investigaytors and Knowledge 2eekerS programs, covers gender-affirming care, sexual behaviour and health, family planning, abortion, cancer prevention, and sexual violence.
Significance: With Pride season underway across Canada in June, the project highlights a documented data gap in sexual and reproductive health for Two-Spirit, queer, and trans communities. (Editorial note:) Better community-level evidence can reasonably be expected to inform more tailored services and product education, an area where Canadian providers and retailers serving diverse customers may find practical relevance.
4. New Forecast Values Global Sexual Wellness Market at $101 Billion by 2035 [RESEARCH — MARKET]
Fact: A Sexual Wellness Market report from Roots Analysis estimates the global market at USD 51.02 billion in 2026, rising to USD 74.64 billion in 2030 and USD 101.18 billion by 2035, a compound annual growth rate of 7.90%. The report places sex toys and vibrators as the largest product segment at 30.21% of 2026 revenue and online stores at roughly 78% of distribution.
Background: The analysis credits growth to destigmatization, e-commerce penetration, femtech adoption, and rising acceptance of sexual-health conversations, with North America holding the largest regional share at 49.86%.
Significance: Forecasts vary widely by firm and should be read as directional rather than definitive. This particular projection reinforces a consistent theme — online channels and pleasure-focused devices remain the growth engine. For Canadian operators, the dominance of discreet e-commerce and the fast-growing women's segment may signal where demand and competition concentrate over the coming decade.
5. Nasstoys Debuts "Sorbet Lavender" Dual-Motor Massager for Retail Channels [TECH — PRODUCT]
Fact: On June 2, 2026, industry outlet JRL Charts reported the launch of the Nasstoys Sorbet Lavender Massager, a rechargeable, dual-motor personal wellness device built in body-safe silicone with a curved shaft, broad tip, and splash-proof, quiet-motor construction aimed at retail distribution.
Background: Nasstoys is a long-established U.S. novelty manufacturer. The launch sits within a broader 2026 product trend toward body-safe materials, rechargeable designs, and devices positioned for mainstream "wellness" shelves rather than traditional adult retail alone.
Significance: Incremental product launches like this illustrate how the mid-market continues to emphasize material safety and everyday usability over novelty. (Editorial note:) For Canadian retailers, the steady stream of silicone, rechargeable, splash-proof designs reflects consumer expectations that intimate devices meet the same hygiene and quality bar as other personal-care goods.
6. STIMULATE Opens Registration for 2026 North American B2B Sexual Wellness Trade Show [INDUSTRY — TRADE]
Fact: STIMULATE, a North American B2B trade show and conference for sexual wellness, intimate care, and adult retail decision-makers, has opened registration for its 2026 flagship event, scheduled for August 3–4, 2026 in Nashville, Tennessee, with more than 30 sessions and two workshop tracks planned.
Background: STIMULATE launched as the first dedicated B2B sexual wellness trade show in the U.S. and has positioned itself around retail, "medtail," and brand connectivity, distinct from the broader adult-industry expo calendar.
Significance: A growing professional trade-show calendar reflects the sector's continued mainstreaming and its appetite for retailer education. This may suggest that buyers — including Canadian retailers sourcing for cross-border product lines — increasingly treat sexual wellness as a structured retail category with its own merchandising and compliance learning curve.
7. Security Study Flags Data Risks in AI Companion Apps as California Rules Take Effect [TECH — PRIVACY]
Fact: A 2026 security review by firm Oversecured examined 17 popular AI companion apps — including products marketed as AI partners and roleplay platforms — and found that ten contained flaws creating a path to users' conversation histories, with six carrying critical vulnerabilities capable of exposing chat data. Separately, California's SB 243, effective January 1, 2026, imposes new disclosure and safety requirements on companion-chatbot operators.
Background: AI companion and intimacy apps handle highly sensitive personal data, from chat logs to authentication tokens, making them an emerging focus for both security researchers and state legislators.
Significance: As intimacy increasingly intersects with software, data protection becomes a wellness issue in its own right. This can reasonably be viewed as an early signal that privacy and security disclosures — not just physical product safety — will shape consumer trust in connected and AI-driven intimate technology, a category Canadian regulators and consumers are likely watching closely.
Editors' Note: What This Month's Stories Mean Together
Three threads run through this issue. The first is that safety in this sector now spans two very different surfaces — the body and the data. The FDA's recall of an adulterated enhancement capsule and the Oversecured findings on AI companion apps sit at opposite ends of the same trust spectrum: one is about what enters the body undisclosed, the other about what leaves a device undisclosed. Both point to disclosure and verification as the consumer's best defence.
The second thread is Canadian institutional momentum. Federal SRH funding and the CBRC's community survey show sexual and reproductive health being treated as public infrastructure and evidence-gathering, not merely a retail category. (Editorial note:) That backdrop can reasonably be expected to shape the education and access environment in which Canadian wellness brands operate.
The third thread is mainstreaming. A double-digit ten-year market forecast, a body-safe retail product launch, and a structured B2B trade calendar all describe an industry steadily professionalizing — moving toward the same standards of material safety, merchandising, and compliance expected of any mature personal-care market. Taken together, the month's stories suggest that credibility, evidence, and safety are becoming the sector's real currency.
— Dr.Chen Wellness Editorial Team, June 10, 2026
References
- U.S. Food and Drug Administration. (2026, May 18). Best Supplements Best Prices Issues Voluntary Nationwide Recall of WAP Sensual Enhancement Capsules Due to Presence of Undeclared Sildenafil, Tadalafil, and Flibanserin. FDA. https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/best-supplements-best-prices-issues-voluntary-nationwide-recall-wap-sensual-enhancement-capsules-due
- Health Canada. (2026, March). Government of Canada Improves Access to Sexual and Reproductive Health Services. Canada.ca. https://www.canada.ca/en/health-canada/news/2026/03/government-of-canada-improves-access-to-sexual-and-reproductive-health-services.html
- Community-Based Research Centre. (2026). Our Bodies, Our Health Survey. CBRC. https://www.cbrc.net/ourbodiesourhealth
- Roots Analysis. (2026). Sexual Wellness Market Size, Trends & Insights Report, 2035. Roots Analysis. https://www.rootsanalysis.com/sexual-wellness-market
- JRL Charts. (2026, June 2). Nasstoys Sorbet Lavender Massager Delivers Dual-Motor Wellness Performance. JRL Charts. https://jrlcharts.com/2026/06/02/nasstoys-sorbet-lavender-massager-delivers-dual-motor-wellness-performance/
- STIMULATE. (2026). STIMULATE — A B2B Sexual Wellness Trade Show + Conference. stimulatetheshow.com. https://stimulatetheshow.com/
- Biometric Update. (2026, March). Aura breach and AI companion app flaws sharpen privacy fears. BiometricUpdate.com. https://www.biometricupdate.com/202603/aura-breach-and-ai-companion-app-flaws-sharpen-privacy-fears
- California State Senate. (2025–2026). SB 243: Companion chatbots. CalMatters Digital Democracy. https://calmatters.digitaldemocracy.org/bills/ca_202520260sb243
